A jury agreed with Pfizer in May and awarded the company $107.5 million in damages. Kennelly ruled for AstraZeneca on Wednesday, finding that the verdict could not stand because the patents lacked valid written descriptions of their inventions and would not enable an ordinary scientist in the field to recreate them.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/uaYiUA1
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment